Investigational Drug Information for KAE609
✉ Email this page to a colleague
What is the development status for investigational drug KAE609?
KAE609 is an investigational drug.
There have been 8 clinical trials for KAE609.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 14th 2023.
The most common disease conditions in clinical trials are Malaria, Malaria, Falciparum, and Malaria, Vivax. The leading clinical trial sponsors are Novartis Pharmaceuticals, Wellcome Trust, and Medicine for Malaria Venture.
There are five US patents protecting this investigational drug and one hundred and ten international patents.
Summary for KAE609
| US Patents | 5 |
| International Patents | 110 |
| US Patent Applications | 20 |
| WIPO Patent Applications | 23 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 2 (2023-09-14) |
| Vendors | 41 |
Recent Clinical Trials for KAE609
| Title | Sponsor | Phase |
|---|---|---|
| Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria | Novartis Pharmaceuticals | Phase 2 |
| To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria | EDCTP within the PAMAFRICA Grant | Phase 2 |
| To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria | European and Developing Countries Clinical Trials Partnership (EDCTP) | Phase 2 |
Clinical Trial Summary for KAE609
Top disease conditions for KAE609
Top clinical trial sponsors for KAE609
US Patents for KAE609
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| KAE609 | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| KAE609 | ⤷ Try a Trial | Methods for treating protozoan infections | NEOCULI PTY LTD. (Burwood, Victoria, AU) | ⤷ Try a Trial |
| KAE609 | ⤷ Try a Trial | Methods for treating protozoan infections | NEOCULI PTY LTD. (Victoria, AU) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for KAE609
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| KAE609 | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| KAE609 | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
| KAE609 | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
